text_1: In rhesus macaques, daily subcutaneous injections of tenofovir protects against rectally transmitted simian-human immunodeficiency virus.
text_2: Short but potent intermittent PrEP can provide protection comparable to that of daily PrEP in this SHIV/macaque model.